Tuesday, July 17, 2018

Roche said on Tuesday its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications from flu, a boost to the Swiss drugmaker's efforts to win approval for the single-dose, oral anti-viral medicine.


from Reuters: Health News https://ift.tt/2zMGpP8

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Giving birth in water, also known as immersion labor and delivery or waterbirth, appears safe for mother and baby, at least when it takes place in a hospital.  from Reuters: Health News https://if… Read More
  • LATEST HEALTH NEWS(Reuters) - Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy ben… Read More
  • LATEST HEALTH NEWSPARIS (Reuters) - Ghana has reported two outbreaks of highly pathogenic H5 bird flu on farms, the Paris-based World Organisation for Animal Health (OIE) said on Friday, citing a report from Ghana's agriculture ministry. … Read More
  • LATEST HEALTH NEWSHigher proportion of Indian women who were pregnant were anaemic in 2016 (50%) when compared to China (32%), Bangladesh (46%), and Nepal (40%), according to data from the World Bank from Health https://ift.tt/2tKRDNJ … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Women with undiagnosed celiac disease may be more likely to have miscarriages or stillbirths than women who never get this diagnosis, a Danish study suggests. from Reuters: Health News https://ift.tt/2… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner